Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-11-08

FDA Approved: ZEPBOUND — Original Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved ZEPBOUND (tirzepatide) from Eli Lilly through an original application for obesity/weight management in adults. This marks the drug's first appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZEPBOUND (tirzepatide)

Snippet

ORIG AP for ZEPBOUND (TIRZEPATIDE)